| Authors: |
Cavaillès C; Université Paris Cité and Université Sorbonne Paris Nord, Inserm U1153, INRAE, Centre for Research in Epidemiology and Statistics, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco., Danilevicz IM; Université Paris Cité and Université Sorbonne Paris Nord, Inserm U1153, INRAE, Centre for Research in Epidemiology and Statistics, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France., Vidil S; Université Paris Cité and Université Sorbonne Paris Nord, Inserm U1153, INRAE, Centre for Research in Epidemiology and Statistics, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France., Fayosse A; Université Paris Cité and Université Sorbonne Paris Nord, Inserm U1153, INRAE, Centre for Research in Epidemiology and Statistics, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France., Chen M; CIRAD, UMR PHIM, Montpellier, France.; PHIM, Univ Montpellier, CIRAD, INRAE, Institut Agro, IRD, Montpellier, France., van Hees V; Accelting, Almere, the Netherlands., Kivimäki M; Faculty of Brain Sciences, University College London, London, United Kingdom., Dugravot A; Université Paris Cité and Université Sorbonne Paris Nord, Inserm U1153, INRAE, Centre for Research in Epidemiology and Statistics, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France., Singh-Manoux A; Université Paris Cité and Université Sorbonne Paris Nord, Inserm U1153, INRAE, Centre for Research in Epidemiology and Statistics, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France.; Faculty of Brain Sciences, University College London, London, United Kingdom., Sabia S; Université Paris Cité and Université Sorbonne Paris Nord, Inserm U1153, INRAE, Centre for Research in Epidemiology and Statistics, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France.; Faculty of Brain Sciences, University College London, London, United Kingdom. |
